SAN ANTONIO, Feb. 9, 2016 -- U.S. Global Investors, Inc. (Nasdaq: GROW) will host a webcast on Tuesday, February 16, at 7:30 a.m. Central time to discuss the company's results for the second quarter of fiscal year 2016.
Financial data for the fiscal year will be released prior to the webcast.
Frank Holmes, CEO and chief investment officer; Susan McGee, president and general counsel; and Lisa Callicotte, chief financial officer, will participate in the webcast.
Click here to register for the quarterly results webcast or visit www.usfunds.com for more information.
About U.S. Global Investors, Inc.
The story of U.S. Global Investors goes back more than 40 years when it began as an investment club. Today, U.S. Global Investors, Inc. (www.usfunds.com) is a registered investment adviser that focuses on niche markets around the world. Headquartered in San Antonio, Texas, the company provides money management and other services to U.S. Global Investors Funds, the U.S. Global Jets ETF and other international clients.
CONTACT: Lisa Aston
Marketing Manager
210.348.2609
[email protected]


Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Italy Fines Apple €98.6 Million Over App Store Dominance
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions 



